Final clinical and molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion: NCT00626990.Martin J. van den Bent, Sara Erridge, Michael A. Vogelbaum et al.|Journal of Clinical Oncology|2025Cited by 5